Philips received a complaint on the efficia dfm100 defibrillator/monitor indicating ta frequent rfu "x" occurrences.Based on the information available, it was determined that this was a malfunction of the dfm100 assy processor, which was replaced, along with 3 lead ecg cable and trunk cable and the device was returned to full functionality.The device remains at the customer site and no further evaluation is warranted at this time.This complaint investigation has been impacted by logistical limitations associated with the service parts supply chain (sps) returns process.This limitation is beyond the immediate control of the complaint handling group.No further investigation of the component is possible until the limitations are resolved.Based on the information available and the testing conducted, the cause of the reported problem was a malfunction of the dfm100 assy processor.The reported problem was confirmed.Based on the information available and results of additional analysis, no further action is necessary at this time.A review of the risk management file was performed, and the potential severity is s3 has been identified in the risk document.The data entered in this complaint record will be utilized for product quality and safety improvements per the post market surveillance and risk management processes.The customer replaced the dfm100 assy processor to resolve the issue.It has been concluded that no further action is required at this time.
|